Antiviral Alternatives Against Important Members of the Subfamily Parvovirinae: a Review

Overview

Journal Arch Virol

Specialty Microbiology

Date 2024 Feb 21

PMID 38378929

Authors

Tamiris Silva Lopes

Vagner Ricardo Lunge

Andre Felipe Streck

Affiliations

Soon will be listed here.

Abstract

Parvoviruses are responsible for multiple diseases, and there is a critical need for effective antiviral therapies. Specific antiviral treatments for parvovirus infections are currently lacking, and the available options are mostly supportive and symptomatic. In recent years, significant research efforts have been directed toward understanding the molecular mechanisms of parvovirus replication and identifying potential targets for antiviral interventions. This review highlights the structure, pathogenesis, and treatment options for major viruses of the subfamily Parvovirinae, such as parvovirus B19 (B19V), canine parvovirus type 2 (CPV-2), and porcine parvovirus (PPV) and also describes different approaches in the development of antiviral alternatives against parvovirus, including drug repurposing, serendipity, and computational tools (molecular docking and artificial intelligence) in drug discovery. These advances greatly increase the likelihood of discoveries that will lead to potent antiviral strategies against different parvovirus infections.

Citing Articles

Identification of Host-Protein Interaction Network of Canine Parvovirus Capsid Protein VP2 in F81 Cells.

Zhou H, Zhang H, Su X, Xu F, Xiao B, Zhang J Microorganisms. 2025; 13(1.

PMID: 39858856 PMC: 11767315. DOI: 10.3390/microorganisms13010088.

Overview of Recent Advances in Canine Parvovirus Research: Current Status and Future Perspectives.

Zhou H, Cui K, Su X, Zhang H, Xiao B, Li S Microorganisms. 2025; 13(1).

PMID: 39858815 PMC: 11767475. DOI: 10.3390/microorganisms13010047.

References

Gallinella G . New Insights into Parvovirus Research. Viruses. 2019; 11(11). PMC: 6893750. DOI: 10.3390/v11111053. View

Mietzsch M, Penzes J, Agbandje-Mckenna M . . Viruses. 2019; 11(4). PMC: 6521121. DOI: 10.3390/v11040362. View

Cotmore S, Agbandje-Mckenna M, Canuti M, Chiorini J, Eis-Hubinger A, Hughes J . ICTV Virus Taxonomy Profile: Parvoviridae. J Gen Virol. 2019; 100(3):367-368. PMC: 6537627. DOI: 10.1099/jgv.0.001212. View

Capozza P, Buonavoglia A, Pratelli A, Martella V, Decaro N . Old and Novel Enteric Parvoviruses of Dogs. Pathogens. 2023; 12(5). PMC: 10223985. DOI: 10.3390/pathogens12050722. View

Manaresi E, Gallinella G . Advances in the Development of Antiviral Strategies against Parvovirus B19. Viruses. 2019; 11(7). PMC: 6669595. DOI: 10.3390/v11070659. View

Zhou H, Su X, Lin L, Zhang J, Qi Q, Guo F . Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in F81 cells. Viruses. 2019; 11(8). PMC: 6724046. DOI: 10.3390/v11080742. View

Kailasan S, Agbandje-Mckenna M, Parrish C . Parvovirus Family Conundrum: What Makes a Killer?. Annu Rev Virol. 2016; 2(1):425-50. DOI: 10.1146/annurev-virology-100114-055150. View

Huang L, Halder S, Agbandje-Mckenna M . Parvovirus glycan interactions. Curr Opin Virol. 2014; 7:108-18. PMC: 4149944. DOI: 10.1016/j.coviro.2014.05.007. View

Caliaro O, Marti A, Ruprecht N, Leisi R, Subramanian S, Hafenstein S . Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations. Viruses. 2019; 11(5). PMC: 6563316. DOI: 10.3390/v11050430. View

10.

Liu P, Chen S, Wang M, Cheng A . The role of nuclear localization signal in parvovirus life cycle. Virol J. 2017; 14(1):80. PMC: 5391597. DOI: 10.1186/s12985-017-0745-1. View

11.

Cotmore S, Tattersall P . Parvovirus diversity and DNA damage responses. Cold Spring Harb Perspect Biol. 2013; 5(2). PMC: 3552509. DOI: 10.1101/cshperspect.a012989. View

12.

Penzes J, Soderlund-Venermo M, Canuti M, Eis-Hubinger A, Hughes J, Cotmore S . Reorganizing the family Parvoviridae: a revised taxonomy independent of the canonical approach based on host association. Arch Virol. 2020; 165(9):2133-2146. DOI: 10.1007/s00705-020-04632-4. View

13.

Tewary S, Zhao H, Shen W, Qiu J, Tang L . Structure of the NS1 protein N-terminal origin recognition/nickase domain from the emerging human bocavirus. J Virol. 2013; 87(21):11487-93. PMC: 3807368. DOI: 10.1128/JVI.01770-13. View

14.

Xie Q, Wang J, Gu C, Wu J, Liu W . Structure and function of the parvoviral NS1 protein: a review. Virus Genes. 2022; 59(2):195-203. DOI: 10.1007/s11262-022-01944-2. View

15.

Tu M, Liu F, Chen S, Wang M, Cheng A . Role of capsid proteins in parvoviruses infection. Virol J. 2015; 12:114. PMC: 4524367. DOI: 10.1186/s12985-015-0344-y. View

16.

Ros C, Bayat N, Wolfisberg R, Almendral J . Protoparvovirus Cell Entry. Viruses. 2017; 9(11). PMC: 5707520. DOI: 10.3390/v9110313. View

17.

Cotmore S, Agbandje-Mckenna M, Chiorini J, Mukha D, Pintel D, Qiu J . The family Parvoviridae. Arch Virol. 2013; 159(5):1239-47. PMC: 4013247. DOI: 10.1007/s00705-013-1914-1. View

18.

Plevka P, Hafenstein S, Li L, DAbrgamo Jr A, Cotmore S, Rossmann M . Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via a pore at a 5-fold axis. J Virol. 2011; 85(10):4822-7. PMC: 3126206. DOI: 10.1128/JVI.02598-10. View

19.

Ganaie S, Qiu J . Recent Advances in Replication and Infection of Human Parvovirus B19. Front Cell Infect Microbiol. 2018; 8:166. PMC: 5996831. DOI: 10.3389/fcimb.2018.00166. View

20.

Kerr J . Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000; 59(9):672-83. PMC: 1753262. DOI: 10.1136/ard.59.9.672. View